Durata's anti-infective drug shows efficacy, safety -FDA panel


(Reuters) – Durata Therapeutics Inc’s drug to treat acute bacterial skin infections shows substantial evidence of safety and efficacy, a panel of advisers to the U.S. Food and Drug Administration concluded on Monday.

The panel voted unanimously in favor of the drug, dalbavancin, paving the way for its approval. The FDA is not obliged to follow the advice of its expert panels but typically does so.

(Reporting by Toni Clarke in Washington; Editing by Peter Cooney)

Visit the Source Site

Nursing body faces Mid-Staffs censure








By Dominic Hughes
Health correspondent, BBC News


NurseThe NMC is the regulator for the nursing profession


The Nursing and Midwifery Council is facing more criticism over its handling of disciplinary cases in a report by the Professional Standards Authority.

In particular, the report highlights failings over the handling of cases relating to the scandal-hit Mid-Staffordshire NHS Trust.

Investigations were poor, decision-making flawed and record-keeping lax, says the PSA.

The NMC is responsible for regulating 673,000 nurses and midwives in the UK.

Smokers may show heart disease much younger than nonsmokers

A man flicks ashes from his cigarette over a dustbin in Shanghai January 10, 2014. REUTERS/Aly Song

A man flicks ashes from his cigarette over a dustbin in Shanghai January 10, 2014.

Credit: Reuters/Aly Song


(Reuters Health) – A smoker’s coronary artery disease is likely to be as advanced as that of a non-smoker who is 10 years older when both show up at the hospital with a heart attack, according to a new study.

Researchers looked at nearly 14,000 patients hospitalized with blockages in arteries supplying the heart muscle and found smokers were more likely than nonsmokers to die within a year.

Obamacare website stalls briefly ahead of enrollment deadline

Julissa Esparza, 2, sleeps in the arms of her grandfather Leobardo Salazar, 58, as they wait in line at a health insurance enrollment event in Cudahy, California March 27, 2014. REUTERS/Lucy Nicholson

Julissa Esparza, 2, sleeps in the arms of her grandfather Leobardo Salazar, 58, as they wait in line at a health insurance enrollment event in Cudahy, California March 27, 2014.

Credit: Reuters/Lucy Nicholson


(Reuters) – The website for people to enroll in U.S. private health insurance faced some delays early Monday morning, just hours before the deadline for the first year of enrollment under the healthcare law.

Are statins good for your love life?

Statins are associated with a significant improvement in erectile function, a fact researchers hope will encourage men who need statins to reduce their risk of heart attack to take them, according to research. “The increase in erectile function scores with statins was approximately one-third to one-half of what has been reported with drugs like Viagra, Cialis or Levitra,” said an author.

Visit the Source Site

Study on effects of cholesterol-lowering medications on sexual health


A new study is giving hope to older men who are concerned about the effects of cholesterol-lowering medications on their sexual health. The study by researchers at Rutgers Robert Wood Johnson Medical School indicates that statin medication prescribed to lower cholesterol and decrease the chance of having a heart attack and stroke, also improves a man’s erectile function. The investigators presented their findings today at the American College of Cardiology‘s Annual Scientific Session and simultaneously released the study in The Journal of Sexual Medicine.

Popular cholesterol-lowering drugs may offer added benefit for men with erectile dysfunction


Statins are associated with a significant improvement in erectile function, a fact researchers hope will encourage men who need statins to reduce their risk of heart attack to take them, according to research to be presented at the American College of Cardiology‘s 63rd Annual Scientific Session.


Erectile dysfunction is common in older men, especially among those with cardiovascular risk factors where cholesterol-lowering statins are frequently prescribed. Previous research has suggested a negative association between statin therapy and testosterone levels, leading to questions about the effects of these widely used medications on the quality of erection.

Newly identified protein markers have potential to contribute to better understanding of heart disease


Researchers at the Intermountain Medical Center Heart Institute in Murray, Utah, have discovered that elevated levels of two recently identified proteins in the body are inflammatory markers and indicators of the presence of cardiovascular disease.


These newly identified markers of inflammation, GlycA and GlycB, have the potential to contribute to better understanding of the inflammatory origins of heart disease and may be used in the future to identify a heart patient’s future risk of suffering a heart attack, stroke, or even death.

Ancient rheumatism drug reduces recurring inflammation around heart


(Reuters) – A drug that was used in the time of the pharaohs for rheumatism has proven highly effective in treating recurrent bouts of pericarditis, an inflammation of the sac surrounding the heart, according to findings of a new clinical trial.

The ancient medicine, colchicine, which has also been used for centuries as an anti-inflammatory agent for acute gout, was tested against placebo in a 240-patient pericarditis trial.

'Step forward' in skin cancer fight








By Helen Briggs
BBC News


MoleFor most people avoiding sunburn and sunbeds is the best way to reduce risk, says Cancer Research UK

Scientists say they have taken a step forward in understanding why some people are at greater risk of skin cancer because of their family history.

A newly identified gene mutation causes some cases of melanoma, a type of skin cancer, says a UK team.

The discovery will pave the way for new screening methods, they report in Nature Genetics.